ATE359508T1 - Screening-verfahren unter verwendung von zebrafisch und der blut-hirn-schranke - Google Patents

Screening-verfahren unter verwendung von zebrafisch und der blut-hirn-schranke

Info

Publication number
ATE359508T1
ATE359508T1 AT05708384T AT05708384T ATE359508T1 AT E359508 T1 ATE359508 T1 AT E359508T1 AT 05708384 T AT05708384 T AT 05708384T AT 05708384 T AT05708384 T AT 05708384T AT E359508 T1 ATE359508 T1 AT E359508T1
Authority
AT
Austria
Prior art keywords
zebrafish
blood
brain barrier
screening methods
brain
Prior art date
Application number
AT05708384T
Other languages
English (en)
Inventor
Paul Goldsmith
Angeleen Louise Fleming
Original Assignee
Daniolabs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32039873&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE359508(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daniolabs Ltd filed Critical Daniolabs Ltd
Application granted granted Critical
Publication of ATE359508T1 publication Critical patent/ATE359508T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AT05708384T 2004-02-17 2005-02-17 Screening-verfahren unter verwendung von zebrafisch und der blut-hirn-schranke ATE359508T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0403490.6A GB0403490D0 (en) 2004-02-17 2004-02-17 Screening methods

Publications (1)

Publication Number Publication Date
ATE359508T1 true ATE359508T1 (de) 2007-05-15

Family

ID=32039873

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05708384T ATE359508T1 (de) 2004-02-17 2005-02-17 Screening-verfahren unter verwendung von zebrafisch und der blut-hirn-schranke

Country Status (10)

Country Link
US (1) US20060193776A1 (de)
EP (1) EP1644733B1 (de)
JP (1) JP2007525665A (de)
AT (1) ATE359508T1 (de)
AU (1) AU2005215455A1 (de)
CA (1) CA2556680A1 (de)
DE (1) DE602005000874T2 (de)
ES (1) ES2286794T3 (de)
GB (1) GB0403490D0 (de)
WO (1) WO2005080974A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7951989B2 (en) * 1998-02-23 2011-05-31 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
WO1999042606A1 (en) 1998-02-23 1999-08-26 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
US6656449B1 (en) 1998-02-23 2003-12-02 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
US20060018833A1 (en) * 2004-04-07 2006-01-26 Randall Murphy Method and system for screening compounds for muscular and/or neurological activity in animals
WO2010031794A1 (en) * 2008-09-22 2010-03-25 Entomopharm Aps Screening methods employing insects with blood brain barrier
JP5733716B2 (ja) * 2009-12-25 2015-06-10 キヤノン株式会社 中枢神経系組織標識用組成物、中枢神経系組織の標識方法、及び中枢神経系組織標識用組成物を用いたスクリーニング方法
EP2517732B1 (de) * 2009-12-25 2016-09-21 Canon Kabushiki Kaisha Transnasale kennzeichnungszusammensetzung für gewebe des zentralen nervensystems
JP5888904B2 (ja) 2011-02-16 2016-03-22 国立大学法人三重大学 中枢神経移行性評価用プローブ、中枢神経移行性評価方法、及び、中枢神経移行性評価用プローブを用いたスクリーニング方法
CN102288750B (zh) * 2011-08-12 2014-04-16 杭州环特生物科技有限公司 斑马鱼p-糖蛋白抑制剂筛选模型的建立方法及其应用
US10143187B2 (en) 2017-02-17 2018-12-04 Denali Therapeutics Inc. Transferrin receptor transgenic models
NZ756763A (en) 2017-02-17 2023-04-28 Denali Therapeutics Inc Engineered transferrin receptor binding polypeptides
US10457717B2 (en) 2017-02-17 2019-10-29 Denali Therapeutics Inc. Engineered polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999042606A1 (en) * 1998-02-23 1999-08-26 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts

Also Published As

Publication number Publication date
ES2286794T3 (es) 2007-12-01
WO2005080974A1 (en) 2005-09-01
AU2005215455A1 (en) 2005-09-01
GB0403490D0 (en) 2004-03-24
EP1644733B1 (de) 2007-04-11
CA2556680A1 (en) 2005-09-01
DE602005000874D1 (de) 2007-05-24
DE602005000874T2 (de) 2008-01-17
JP2007525665A (ja) 2007-09-06
EP1644733A1 (de) 2006-04-12
US20060193776A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
DE602005025106D1 (de) Methoden zur medikamentenaufspürung auf der basis von in vitro differenzierten zellen
ATE457773T1 (de) Mittel zur funktionalen wiederherstellung eines geschädigten nervensystems
DE602005000874D1 (de) Screening-verfahren unter verwendung von zebrafisch und der blut-hirn-schranke
ATE397676T1 (de) Identifikation und verwendung von mirnas zur differenzierung myelogener leukämiezellen
NO20092741L (no) DR6-antagonister og anvendelse derav ved behandling av neurologiske forstyrrelser
DE602005020209D1 (de) System zur Evaluierung von Herzstörungen
CY1114443T1 (el) Απταμερη θεραπευτικα χρησιμα στην αντιμετωπιση των σχετικων με το συμπληρωμα διαταραχων
EP1948296A4 (de) Kabelloser herzschrittmacher und system
ATE465412T1 (de) Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen
ATE475432T1 (de) Arzneimittel für herzversagen
WO2007084979A3 (en) Method to quantitatively measure effect of psychotropic drugs on sensory discrimination
ATE525648T1 (de) Testelement mit nanofasern
GB2473575A (en) Treatment and diagnosis of behavioural disorders
MXPA05009743A (es) Composiciones con actividad hematopoyetica e inmune.
EP1862433A4 (de) Personalisierter synthetischer diamant mit verschiedenen farben, erhalten aus keratin (lebender oder toter) menschen oder tiere und herstellungsverfahren dafür
DE602006013143D1 (de) Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate
ATE516496T1 (de) Verfahren zur in-vivo-suche nach kardiotoxischen substanzen mit teleost
WO2005016279A3 (en) Melks as modifiers of the rac pathway and methods of use
EP1898950A4 (de) Galk1s als modifikatoren des pten/akt-wegs und verwendungsverfahren
ATE536549T1 (de) Galnts als modifikatoren des igfr-weges und verwendungsverfahren
ATE494551T1 (de) C20orf23 als modifikator des igfr-wegs und verwendungsverfahren
ATE501278T1 (de) Verfahren zur verwendung von il-21
WO2005072475A3 (en) Itpks as modifiers of the igfr pathway and methods of use
WO2006017621A3 (en) IRAK1c SPLICE VARIANT AND ITS USE
NO20091627L (no) Fremgangsmate for identifisering av potensielle biomarkorer og medikamentmal i hjerneplastisitetsrelaterte forstyrrelser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties